1
|
Park N, Correa Medina M, Martinez F, Throssel M, Dasgupta A, Knopfelmacher A, Villamin C, Rivas S, Tomczak N, Garg S, Layton L, Klein K. Trend towards reduction of transfusion reactions using prestorage leukocyte-reduced and pooled whole blood-derived platelets and cost savings compared with poststorage whole blood-derived random platelets as evidenced by real-time hemovigilance. Lab Med 2024; 55:251-254. [PMID: 38175635 DOI: 10.1093/labmed/lmad106] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/05/2024] Open
Abstract
BACKGROUND Due to chemotherapy-induced neutropenia or hematologic malignancies, immunocompromised cancer patients may have higher incidence of febrile nonhemolytic transfusion reactions compared with the general population and frequently require platelet transfusions. This quality improvement project compared the safety of transfusion using prestorage leukocyte-reduced and pooled whole blood-derived platelets (Acrodose/WBD) with conventionally produced poststorage WBD platelets (RDP) using an active hemovigilance system. METHODS Every patient receiving a blood product at the hospital was virtually monitored in real time by trained nurses from a remote hemovigilance unit. These nurses monitor a digital dashboard, which populates a watch list of patients from the time blood product administration is initiated until 12 hours posttransfusion. Over the course of 6 months, 371 patients receiving 792 RDP transfusions and 423 patients receiving 780 Acrodose/WBD platelets transfusions were monitored for transfusion reactions. RESULTS We identified 26 transfusion reactions in RDP but only 12 transfusion reactions in the Acrodose/WBD platelet group. CONCLUSION Acrodose platelet transfusion was associated with fewer transfusion reactions, which resulted in significant cost savings.
Collapse
Affiliation(s)
- Nick Park
- Department of Laboratory Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX, US
| | - Mayrin Correa Medina
- Department of Laboratory Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX, US
| | - Fernando Martinez
- Department of Laboratory Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX, US
| | - Marla Throssel
- Department of Laboratory Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX, US
| | - Amitava Dasgupta
- Department of Pathology and Laboratory Medicine University of Kansas Medical Center, Kansas City, KS, US
| | - Adriana Knopfelmacher
- Department of Laboratory Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX, US
| | - Colleen Villamin
- Department of Laboratory Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX, US
| | - Sandra Rivas
- Department of Laboratory Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX, US
| | - Nancy Tomczak
- Department of Laboratory Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX, US
| | - Saahith Garg
- Department of Biochemistry, University of Texas Health Science Center at Houston, Houston, TX, US
| | - Lorraine Layton
- Department of Laboratory Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX, US
| | - Kimberly Klein
- Department of Laboratory Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX, US
| |
Collapse
|
2
|
Kaplan A. Preparation, Storage, and Characteristics of Whole Blood, Blood Components, and Plasma Derivatives. Transfus Med 2021. [DOI: 10.1002/9781119599586.ch5] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/08/2022]
|